Seres Therapeutics Inc (MCRB) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Seres Therapeutics Inc   (NASDAQ: MCRB)

Seres Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MCRB Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 70.91 % 65.43 % 46.06 %
Gross Margin (Q2 TTM) 60.91 % 71.73 % 66.39 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 66.05 % 64.67 % 47.07 %
EBITDA Margin (Q2 MRQ) 66.44 % 22.25 % 19.62 % 20.6 %
EBITDA Margin (Q2 TTM) -1262.67 % 25.28 % 20.88 % 19.1 %
EBITDA Margin 5 Yr. Avg. - 45.98 % 31.17 % 22.06 %
Operating Margin (Q2 MRQ) -2890.35 % 17.27 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) -4462.77 % 20.33 % 17.92 % 16.33 %
Operating Margin 5 Yr. Avg. - 15.55 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 13.66 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) -1436.22 % 16.7 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.09 % 10.45 % 12.49 %
Net Margin (Q2 MRQ) 622.42 % 10.09 % 8.14 % 11.41 %
Net Margin (Q2 TTM) -1192.94 % 13.13 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. - 6.22 % 6.23 % 9.95 %